Abstract
Preference-based measures of health are used in economic evaluation as a measure of health benefit. The commonly used EQ-5D may not be very sensitive to cognitive impairment in schizophrenia compared to interview-based cognitive functioning measures such as the Schizophrenia Cognition Rating Scale (SCoRS). The purpose of this study was to select and value key dimensions of cognitive impairment described by the SCoRS to estimate utilities.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
